A SHR0302 BA Study on Healthy Subjects

NCT06202612 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: SHR0302 quick release tablets
DRUG: SHR0302 sustained-release tablets

Sponsor

Jiangsu HengRui Medicine Co., Ltd.